Article

Hidradenitis Suppurativa May Precede Inflammatory Arthritis

A diagnosis of hidradenitis suppurativa may precede the development of ankylosing spondylitis, psoriatic arthritis or rheumatoid arthritis in patients, say researchers writing in the January 22 issue of JAMA Dermatology.

Is hidradenitis suppurativa a precursor to inflammatory arthritis?

(©Supawadee. AdobeStock_125267749)

A diagnosis of hidradenitis suppurativa may precede the development of ankylosing spondylitis, psoriatic arthritis or rheumatoid arthritis in patients, say researchers writing in the January 22 issue of JAMA Dermatology.

The findings are based on an analysis of health insurance claims data (including Medicaid and Medicare) of 70,697 patients (mean age 36.5 years) in the U.S. who were diagnosed with hidradenitis suppurativa (HS) between 2003 and 2016; and, 141,412 patients without HS.

Most patients were female (78.0% vs 52.0%) and they tended to have an increased burden of comorbidities, such as psoriasis and inflammatory bowel disease. The average follow-up period was 1.5 years.

Prior to the onset of HS, patients in both groups were arthrits free, wrote researchers in this research letter by Maria C. Schneeweiss, M.D., et al. But patients had an increased risk for developing ankylosing spondylitis compared to patiens without HS (incidence rate, 0.60 vs 0.36 per 1000; HR, 1.65 [95% CI, 1.15-2.35]); psoriatic arthritis (incidence rate, 0.84 vs 0.58 per 1000; HR, 1.44 [95% CI, 1.08-1.93]), and rheumatoid arthritis (incidence rate, 4.54 vs 3.86 per 1000; HR, 1.16 [95% CI, 1.03-1.31]).

The actual number of HS patients who went on to develop an inflammatory arthritis was low with only 2-6 cases per 10,000 patients. Although low, the data still points to an association between HS and inflammatory joint disease.

"Nevertheless, physicians treating patients with HS should be aware of symptoms suggestive of inflammatory arthritis, including morning stiffness and joint pain or swelling. This study cannot prove a causal relationship between HS and inflammatory arthritis, and further work is needed to elucidate the underlying potential shared pathogenesis of these disorders," researchers wrote.

REFERENCE: Maria C. Schneeweiss, MD; Seoyoung C. Kim, MD, ScD; Sebastian Schneeweiss, MD, ScD; et al. "Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa,"JAMA Dermatology. Jan. 22, 2020. DOI:10.1001/jamadermatol.2019.4590

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.